The Lancet Oncology — Journal Profile & Submission Links
Elsevier Ltd · ISSN-L 1470-2045
Source-backed journal profile with OpenAlex metadata and links to official submission resources for The Lancet Oncology.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- www.thelancet.com/journals/lanonc
- Author guidelines
- www.sciencedirect.com/journal/the-lancet-oncology/publish/gu…
- Submission portal
- www.editorialmanager.com/THELANCETONCOLOGY/default.aspx
Catalog scope notes
The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.
Catalog source: merged. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- www.editorialmanager.com/THELANCETONCOLOGY/default.aspx
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.